Related Experiment Video
Updated: Oct 27, 2025

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Clinical findings associated with incomplete hemodynamic left ventricular unloading in patients with a left
María J Ruiz-Cano1, René Schramm1, Lech Paluszkiewicz1
1Division of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW Bad Oeynhausen, Ruhr-University Bochum, Germany.
Insights
Optimal hemodynamic left ventricular unloading (HLVU) is achievable in 72% of centrifugal continuous-flow left ventricular assist device (cfLVAD) patients. Brain natriuretic peptide levels and reverse left ventricular remodeling can help assess HLVU.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Hemodynamic left ventricular unloading (HLVU) is crucial for patients with centrifugal continuous-flow left ventricular assist devices (cfLVADs).
- The factors influencing successful HLVU and hemodynamic optimization are not fully understood.
Purpose of the Study:
- To assess the incidence of incomplete HLVU in ambulatory cfLVAD patients.
- To identify clinical, hemodynamic, and echocardiographic predictors of incomplete HLVU.
Main Methods:
- Retrospective analysis of 104 ambulatory cfLVAD patients.
- Evaluation of high pulmonary capillary wedge pressure (hPCWP > 15mmHg) as a marker for incomplete HLVU.
- Assessment of variables predicting hPCWP.
Main Results:
- Twenty-eight percent of patients experienced incomplete HLVU (hPCWP).
- Higher risk of hPCWP was associated with age, central venous pressure, absence of RAAS inhibitors, and elevated BNP levels.
- Brain natriuretic peptide <300 pg/mL predicted freedom from hPCWP with 86% NPV.
Conclusions:
- Optimal HLVU is achievable in up to 72% of cfLVAD patients using current speed setting recommendations.
- Age, central venous pressure, and RAAS inhibitor therapy significantly impact HLVU.
- BNP levels and left ventricular remodeling are valuable noninvasive tools for HLVU assessment.
Introduction And Objectives:
The effect of a centrifugal continuous-flow left ventricular assist device (cfLVAD) on hemodynamic left ventricular unloading (HLVU) and the clinical conditions that interfere with hemodynamic optimization are not well defined.
Methods:
We retrospectively evaluated the likelihood of incomplete HLVU, defined as high pulmonary capillary wedge pressure (hPCWP)> 15mmHg in 104 ambulatory cfLVAD patients when the current standard recommendations for cfLVAD rotor speed setting were applied. We also evaluated the ability of clinical, hemodynamic and echocardiographic variables to predict hPCWP in ambulatory cfLVAD patients.
Results:
Twenty-eight percent of the patients showed hPCWP. The variables associated with a higher risk of hPCWP were age, central venous pressure, absence of treatment with renin-angiotensin-aldosterone system inhibitors, and brain natriuretic peptide levels. Patients with optimal HLVU had a 15.2±14.7% decrease in postoperative indexed left ventricular end-diastolic diameter compared with 8.9±11.8% in the group with hPCWP (P=.041). Independent predictors of hPCWP included brain natriuretic peptide and age. Brain natriuretic peptide <300 pg/mL predicted freedom from hPCWP with a negative predictive value of 86% (P <.0001).
Conclusions:
An optimal HLVU can be achieved in up to 72% of the ambulatory cfLVAD patients when the current standard recommendations for rotor speed setting are applied. Age, central venous pressure and therapy with renin-angiotensin-aldosteron system inhibitors had a substantial effect on achieving this goal. Brain natriuretic peptide levels and the magnitude of reverse left ventricular remodeling seem to be useful noninvasive tools to evaluate HLVU in patients with functioning cfLVAD.
More Related Videos
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Heart Failure III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection